Matthias Zeis

2.2k total citations
42 papers, 931 citations indexed

About

Matthias Zeis is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Matthias Zeis has authored 42 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 20 papers in Hematology and 13 papers in Molecular Biology. Recurrent topics in Matthias Zeis's work include Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (14 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Matthias Zeis is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (14 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Matthias Zeis collaborates with scholars based in Germany, United States and Croatia. Matthias Zeis's co-authors include Norbert Schmitz, Lutz Uharek, Jörg Steinmann, Peter Dreger, Sandra Siegel, Andreas Wagner, Bertram Glaß, L. Uharek, B. Glaß and Dieter Kabelitz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Matthias Zeis

41 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Zeis Germany 16 634 368 314 229 104 42 931
Chiara Gentilini Germany 14 605 1.0× 252 0.7× 396 1.3× 177 0.8× 57 0.5× 24 932
Anouk Caraux France 11 717 1.1× 179 0.5× 167 0.5× 258 1.1× 106 1.0× 15 1.0k
G Risdon United States 11 394 0.6× 388 1.1× 216 0.7× 137 0.6× 98 0.9× 14 843
Cornelis A.M. van Bergen Netherlands 20 949 1.5× 622 1.7× 480 1.5× 232 1.0× 67 0.6× 53 1.3k
Shingo Urata Japan 6 409 0.6× 280 0.8× 276 0.9× 257 1.1× 127 1.2× 9 784
J Daley United States 8 627 1.0× 149 0.4× 254 0.8× 140 0.6× 79 0.8× 9 799
Marlies Götz Germany 14 358 0.6× 326 0.9× 276 0.9× 224 1.0× 31 0.3× 32 682
MK Brenner United Kingdom 10 310 0.5× 320 0.9× 213 0.7× 174 0.8× 58 0.6× 16 723
Dina Stroopinsky United States 14 315 0.5× 193 0.5× 295 0.9× 392 1.7× 107 1.0× 46 835
David Ciarlariello United States 7 487 0.8× 225 0.6× 320 1.0× 487 2.1× 44 0.4× 9 971

Countries citing papers authored by Matthias Zeis

Since Specialization
Citations

This map shows the geographic impact of Matthias Zeis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Zeis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Zeis more than expected).

Fields of papers citing papers by Matthias Zeis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Zeis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Zeis. The network helps show where Matthias Zeis may publish in the future.

Co-authorship network of co-authors of Matthias Zeis

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Zeis. A scholar is included among the top collaborators of Matthias Zeis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Zeis. Matthias Zeis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merz, Maximilian, Mathias Haenel, Uta Bertsch, et al.. (2015). Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma. Blood. 126(23). 4233–4233. 2 indexed citations
2.
3.
Zenz, Thorsten, Peter Dreger, Sascha Dietrich, et al.. (2010). Allogeneic Stem Cell Transplantation Can Overcome the Adverse Prognostic Impact of TP53 Mutation In Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3x Trial. Blood. 116(21). 2357–2357. 5 indexed citations
4.
Friedrichs, Birte, Sandra Siegel, Marita Kloess, et al.. (2008). Humoral Immune Responses against the Immature Laminin Receptor Protein Show Prognostic Significance in Patients with Chronic Lymphocytic Leukemia. The Journal of Immunology. 180(9). 6374–6384. 15 indexed citations
5.
Siegel, Sandra, Andreas Wagner, Birte Friedrichs, et al.. (2006). Identification of HLA-A*0201-Presented T Cell Epitopes Derived from the Oncofetal Antigen-Immature Laminin Receptor Protein in Patients with Hematological Malignancies. The Journal of Immunology. 176(11). 6935–6944. 25 indexed citations
6.
Friedrichs, Birte, Sandra Siegel, Mads Hald Andersen, Norbert Schmitz, & Matthias Zeis. (2006). Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies. Leukemia & lymphoma. 47(6). 978–985. 16 indexed citations
7.
Zeis, Matthias, Sandra Siegel, Andreas Wagner, et al.. (2003). Generation of Cytotoxic Responses in Mice and Human Individuals Against Hematological Malignancies Using Survivin-RNA-Transfected Dendritic Cells. The Journal of Immunology. 170(11). 5391–5397. 86 indexed citations
8.
Siegel, Sandra, Andreas Wagner, Norbert Schmitz, & Matthias Zeis. (2003). Induction of antitumour immunity using survivin peptide‐pulsed dendritic cells in a murine lymphoma model. British Journal of Haematology. 122(6). 911–914. 48 indexed citations
9.
Zeis, Matthias, et al.. (2002). Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice. Bone Marrow Transplantation. 29(3). 213–221. 10 indexed citations
10.
11.
Zeis, Matthias, et al.. (2002). Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma. British Journal of Haematology. 117(1). 93–102. 5 indexed citations
12.
Zeis, Matthias, et al.. (2001). Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice. Bone Marrow Transplantation. 27(3). 279–285. 9 indexed citations
13.
Zeis, Matthias, et al.. (2001). Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice. The Hematology Journal. 2(2). 136–144. 14 indexed citations
14.
15.
Glaß, B., L. Uharek, Matthias Zeis, et al.. (1998). Immunotherapeutic aspects of allogeneic peripheral progenitor cells.. PubMed. 21 Suppl 3. S3–8. 5 indexed citations
16.
Uharek, L., Matthias Zeis, B. Glaß, et al.. (1998). Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone.. PubMed. 21 Suppl 3. S16–20. 9 indexed citations
17.
Zeis, Matthias, L. Uharek, B. Glaß, et al.. (1997). Allogeneic MHC‐mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft‐versus‐leukaemia effect in mice. British Journal of Haematology. 96(4). 757–761. 44 indexed citations
18.
Glaß, Bertram, Lutz Uharek, Matthias Zeis, et al.. (1997). Allogeneic Peripheral Blood Progenitor Cell Transplantation in a Murine Model: Evidence for an Improved Graft-Versus-Leukemia Effect. Blood. 90(4). 1694–1700. 51 indexed citations
19.
Zeis, Matthias, et al.. (1995). ALLOGENEIC NK CELLS AS POTENT ANTILEUKEMIC EFFECTOR CELLS AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION IN MICE. Transplantation. 59(12). 1734–1736. 39 indexed citations
20.
Zeis, Matthias, L. Uharek, B. Glaß, et al.. (1994). Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.. PubMed. 14(5). 711–5. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Gentilini Breakdown of academic impact, for papers by Anouk Caraux Breakdown of academic impact, for papers by G Risdon Breakdown of academic impact, for papers by Cornelis A.M. van Bergen Breakdown of academic impact, for papers by Shingo Urata Breakdown of academic impact, for papers by J Daley Breakdown of academic impact, for papers by Marlies Götz Breakdown of academic impact, for papers by MK Brenner Breakdown of academic impact, for papers by Dina Stroopinsky Breakdown of academic impact, for papers by David Ciarlariello
Rankless by CCL
2026